glp-1 oral medication for weight loss FDA approves Foundayo, an alternative to Wegovy and Ozempic crave less FDA Approves Oral Semaglutide: First

Be Patient and Set Realistic Expectations Healthy progress on GLP1s is often steady but not perfectly linear

Like other chronic conditions, it requires long-term treatment. GLP-1 Injections Several GLP-1 medications for weight loss are available as injections, including Zepbound, Wegovy and Saxenda

Or should someone stop levothyroxine when levels are normalized?)

The indications are there

December 2, 2025: Modest Growth for Ozempic Gastroparesis MDL There are now 2,947 active lawsuits in the MDL focused on claims involving GLP-1 drugs and intestinal conditions like gastroparesis

Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected as new entrants including Boehringer Ingelheim, Amgen, Pfizer and Roche offer novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly)